Skip to content

TME-Activated Nanofactory Orchestrate NIR-II Fluorescence/Photoacoustic Imaging-Guided Synergistic Chemodynamic/Photothermal Antitumor Therapy.

Sep 2026 · Macromolecular rapid communications · pp. e70434 · 0 citations · 17 references
Medicine

TL;DR

A novel responsive multifunctional Ag2S/MnO2@SiO2@SiO2 (AMS) nanofactory was constructed for NIR-II fluorescence/photoacoustic (NIR-II FL/PA) imaging-guided synergistic chemodynamic/photothermal therapy (CDT/PTT) of TNBC.

Abstract

Triple-negative breast cancer (TNBC) is a highly aggressive and lethal malignancy with poor response to conventional therapeutic regimens. Thus, there is an urgent need to develop precision theranostic nanoplatforms that integrate accurate imaging guidance with synergistic therapeutic modalities. Herein, a novel responsive multifunctional Ag2S/MnO2@SiO2 (AMS) nanofactory was constructed for NIR-II fluorescence/photoacoustic (NIR-II FL/PA) imaging-guided synergistic chemodynamic/photothermal therapy (CDT/PTT) of TNBC. Leveraging the unique biochemical cues of the TME, AMS undergoes efficient degradation, leading to the rapid release of Ag2S and Mn2+ ions. The released Ag2S enables precise tumor localization via NIR-II FL/PA imaging, while simultaneously mediating efficient PTT upon 808 nm laser irradiation. Meanwhile, Mn2+ ions exhibit Fenton-like catalytic activity to convert endogenous H2O2 into highly toxic •OH for CDT, and the hyperthermia induced by PTT further accelerates the Fenton-like reaction to boost CDT efficacy, thus achieving highly efficient synergistic antitumor therapy. Collectively, the AMS nanofactory with favorable biocompatibility provides a promising strategy for precision theranostics of TNBC.

View source

Similar papers

Sep 2026

Multimodal Imaging Guided Synergistically Therapy in Hypoxic Tumor based on α-NaYbF4:Tm@Cu2-xSe@ZnFe2O4-DOX Nanoplatforms Mediated by NIR Light.

The aberrant vascularization and uneven vascular distribution stemming from rapid tumor cell proliferation culminate arouse intra-tumoral hypoxia, which substantially compromises the therapeutic response to conventional chemotherapy, as well as photothermal therapy (PTT) and photodynamic therapy (PDT). In this work, we...

Qi Cai, Yue Li, Xue-Wei Ba et al. · 0 citations
Sep 2026

Enzyme-like bimetallic nanoclusters modulate tumor microenvironment to enhance radiosensitization for multimodal imaging and synergistic photothermal-radiotherapy.

This TME-responsive bimetallic nanoplatform successfully integrates radiosensitization, multimodal imaging, and PTT, offering a robust strategy for imaging-guided precision cancer therapy.

Rui-Ying Zhang, Miao-Qing Li, Rui Cao et al. · 0 citations
Oct 2026

Dual-Responsive Dextran-Based Nanosystem for NIR Dual-Modal Imaging-Guided Photothermal-Chemotherapy of Breast Cancer.

Breast cancer is a highly prevalent malignancy, but the conventional single chemotherapy suffers from insufficient therapeutic outcomes. To overcome this challenge, this study developed a dextran-based prodrug nanogel (DDIR) with dual pH/GSH responsiveness to the tumor microenvironment, enabling near-infrared (NIR) flu...

Fan-Peng Ran, Qi-Han Wang, Meng-Lin Zhang et al. · 0 citations
Sep 2026

Rational Design of a Smart Phototheranostic Nanoagent Based on a NIR-II-Conjugated Polymer for Highly Tumor-Specific Multimodal Imaging-Guided Synergistic Therapy.

A smart phototheranostic nanoagent that simultaneously combined active tumor targeting and TME response for highly tumor-specific multimodal imaging-guided synergistic PDT/PTT/CDT, providing a simple and universal strategy for enhancing the precision and efficiency of phototheranostics.

Gui-Ce Ding, Yi-Ling Wang, Yan-Qin Huang et al. · 0 citations
Open access Sep 2026

Programmable Organic A2S-TT NPs for NIR-II/Photoacoustic Imaging-Enabled Precision Therapy

A2S-TT NPs achieved precise, efficient, safe, and controllable PDT through dual-mode imaging using NIR-II and PA, providing a novel strategy with clinical translation potential for the integrated diagnosis and treatment of TNBC.

Wei Sang, Yi-Jun Huang, Jia-Hui Wen et al. · 0 citations
Oct 2026

Photothermal-driven surface redox reconstruction of Mn3+-engineered α-MoO3/MnOx nanozyme for triple-negative breast cancer therapy.

Triple-negative breast cancer (TNBC) remains a highly aggressive malignancy with limited therapeutic options. Herein, a Mn3+-engineered α-MoO3/MnOx (MM) nanozyme was developed for synergistic photothermal and chemodynamic therapy of TNBC. The strongly coupled MM heterointerface facilitated efficient electron transfer a...

Qin Gao, Ying-Ping Chen, Ke Li et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.